Neuraxis Inc (NRXS)

Currency in USD
7.000
-0.380(-5.15%)
Closed·
7.140+0.140(+2.00%)
·
NRXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.9507.490
52 wk Range
2.1969.330
Key Statistics
Prev. Close
7.38
Open
7.39
Day's Range
6.95-7.49
52 wk Range
2.196-9.33
Volume
115.46K
Average Volume (3m)
189.38K
1-Year Change
131.0231%
Book Value / Share
0.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NRXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.000
Upside
+57.14%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Neuraxis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.000
(+57.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy13.00+85.71%8.00Maintain20/03/2026
Craig-Hallum
Buy8.00+14.29%7.00Maintain22/12/2025
Craig-Hallum
Buy7.00--New Coverage16/06/2025

Neuraxis Inc Earnings Call Summary for Q1/2026

  • Neuraxis posted record Q1 2026 revenue of $1.6M, up 80% YoY, marking seventh consecutive quarter of double-digit growth.
  • Gross margin expanded 200 basis points to 86.4%; operating and net losses improved 24% and 23% respectively to $1.7M and $1.8M.
  • Stock surged 6.38% in pre-market to $8.67, with shares up 251% over past year; company holds $7.1M cash as of March 31.
  • Management projects continued margin expansion and targets cash burn reduction to $1M or less per quarter from Q2-Q4 2026.
  • Growth driven by 32% increase in IB-Stim deliveries and 33% higher average selling price, aided by expanded insurance coverage.
Last Updated: 12/05/2026, 16:50
Read Full Transcript

Earnings

Latest Release
12/05/2026
EPS / Forecast
-0.18 / -0.22
Revenue / Forecast
1.61M / --
EPS Revisions
Last 90 days

Compare NRXS to Peers and Sector

Metrics to compare
NRXS
Peers
Sector
Relationship
P/E Ratio
−10.0x−8.1x−0.5x
PEG Ratio
−0.29−0.290.00
Price/Book
14.0x8.3x2.6x
Price / LTM Sales
18.8x6.4x3.1x
Upside (Analyst Target)
57.1%72.8%52.5%
Fair Value Upside
Unlock−8.8%6.0%Unlock

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
351.58K3.06%2.59M
Other Institutional Investors
2.14M18.62%15.81M
Public Companies & Retail Investors
9.01M78.32%66.50M
Total
11.51M100.00%84.91M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Index Funds - Vanguard Total Stock Market ETF1.09%125,735928
Vanguard Index Funds - Vanguard Extended Market ETF0.87%100,132739

People Also Watch

295.88
MOD
+13.57%
390.75
MTZ
+2.26%
742.18
PWR
+2.59%
119.16
CF
-2.09%
1,589.55
SNDK
+7.50%

FAQ

What Is the Neuraxis (NYSE: NRXS) Share Price Today?

The Neuraxis stock price today is 7.000 USD.

What Stock Exchange Does Neuraxis (NRXS) Trade On?

Neuraxis is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Neuraxis?

The stock symbol (also called a 'ticker') for Neuraxis is "NRXS."

What Is the Current Neuraxis Market Capitalisation?

As of today, Neuraxis (NYSE: NRXS) market cap is 84.910M USD.

What Is Neuraxis's (NRXS) Earnings Per Share (TTM)?

The Neuraxis EPS is currently -0.816 (Trailing Twelve Months).

When Is the Next Neuraxis Earnings Date?

Neuraxis's next earnings report will be released on 12/05/2026.

Is NRXS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Neuraxis moving averages and other technical indicators, the daily buy/sell signal for NRXS stock is Strong Sell.

How Many Times Has Neuraxis Stock Split?

Neuraxis has split 0 times. (See the NRXS stock split history page for full effective split date and price information.)

How Many Employees Does Neuraxis Have?

Neuraxis has 24 employees, based on their latest Companies House report.

What is the current trading status of Neuraxis (NYSE: NRXS)?

As of 26/05/2026, Neuraxis (NRXS) is trading at a share price of 7.000 USD, with a previous close of 7.380 USD. The stock has fluctuated within a day range of 6.950 USD to 7.490 USD, while its 52-week range spans from 2.196 USD to 9.330 USD.

What Is Neuraxis (NRXS) Price Target According to Analysts?

The average 12-month price target for Neuraxis is 11.000 USD, with a high estimate of 13 USD and a low estimate of 9 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +57.14% Upside potential.

What Is the NRXS Premarket Price?

NRXS's last pre-market stock price is 7.340 USD. The pre-market share volume is 2,430.000, and the stock has decreased by -0.040, or -0.540%.

What Is the NRXS After Hours Price?

NRXS's last after hours stock price is 7.140 USD, the stock has decreased by 0.140, or 2.000%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.